Head-To-Head Review: Astrana Health (NASDAQ:ASTH) versus Xcelerate (OTCMKTS:XCRT)

Xcelerate (OTCMKTS:XCRT) and Astrana Health (NASDAQ:ASTH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.

Institutional & Insider Ownership

52.8% of Astrana Health shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Xcelerate and Astrana Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Xcelerate	N/A	N/A	N/A
Astrana Health	0.86%	9.22%	3.54%

Earnings & Valuation

This table compares Xcelerate and Astrana Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xcelerate	N/A	N/A	N/A	N/A	N/A
Astrana Health	$3.18 billion	0.82	$22.49 million	$0.61	77.11

Astrana Health has higher revenue and earnings than Xcelerate.

Analyst Recommendations

This is a summary of current ratings for Xcelerate and Astrana Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xcelerate	0	0	0	0	0.00
Astrana Health	0	2	7	0	2.78

Astrana Health has a consensus target price of $45.00, suggesting a potential downside of 4.34%. Given Astrana Health’s stronger consensus rating and higher probable upside, analysts clearly believe Astrana Health is more favorable than Xcelerate.

Risk & Volatility

Xcelerate has a beta of 1.72, suggesting that its stock price is 72% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500.

Summary

Astrana Health beats Xcelerate on 9 of the 10 factors compared between the two stocks.

About Xcelerate

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.